A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Nonalcoholic Steatohepatitis (NASH)
Interventions
DRUG

Efimosfermin

Efimosfermin will be administered by subcutaneous injection

DRUG

Placebo

Placebo will be administered by subcutaneous injection

Trial Locations (48)

28304

Coastal Research Institute, LLC, Fayetteville

32127

Progressive Medical Research, Port Orange

32803

Charter Research, Orlando

33014

Panex Clinical Research, Miami Lakes

33016

Evolution Clinical Trials, Hialeah Gardens

33126

G+C Research Group, Miami

33155

Miami Clinical Research, Miami

33156

Advanced Clinical Research, Miami

33173

Admed Research, Miami

Century Research, Miami

33176

Entrust Clinical Research Center, Kendall

33907

Southwest General Healthcare Center, Fort Myers

33912

Covenant Metabolic Specialists - Fort Myers, Fort Myers

33976

Galenus Group, Lehigh Acres

34240

Covenant Metabolic Specialists - Sarasota, Sarasota

35205

Central Research Associates, Birmingham

58104

Lillestol Research LLC, Fargo

64131

Kansas City Research Institute, Kansas City

70072

Tandem Clinical Research, Marrero

75839

South Texas Research Institute-Edinburg, Edinburg

76710

Velocity Clinical Research - Waco, Waco

77079

Houston Research Institute, Houston

77401

Apex Mobile Clinical Research, Bellaire

77584

LinQ Research, LLC, Pearland

78209

Quality Research, Inc, San Antonio

78215

American Research Corporation at Texas Liver Institute, San Antonio

78229

Pinnacle Clinical Research - San Antonio, San Antonio

78520

South Texas Research Institute-Brownsville, Brownsville

78626

Pinnacle Clinical Research - Georgetown, Georgetown

78745

Accelemed Research, Austin

78757

Pinnacle Clinical Research - Austin, Austin

Texas Liver Institute - Austin, Austin

84117

Olympus Family Medicine, Salt Lake City

84405

South Ogden Family Medicine, South Ogden

85224

Arizona Liver Health, Chandler

85381

Arizona Liver Health, Peoria

85712

Arizona Liver Health, Tucson

Liver Institute PPLC, Tucson

QLMC, Tucson

91304

Alliance Research Institute, Canoga Park

91763

Catalina Research Institute, Montclair

92377

Inland Empire Clinical Trials, Rialto

92708

Ark Clinical Research, Fountain Valley

92720

Fresno Clinical Research Center, Fresno

92868

Knowledge Research Center, Orange

93030

FOMAT Medical Research, Oxnard

98105

Liver Institute NorthWest, Seattle

02818

Velocity Clinical Research, East Greenwich

All Listed Sponsors
collaborator

GSK Research and Development Limited

UNKNOWN

lead

Boston Pharmaceuticals

INDUSTRY